Payer AI

Payer AI covers the AI systems on the payer side of the U.S. healthcare economy — the tools health plans, PBMs, MACs, and (increasingly) hospital revenue-cycle teams use to review claims, run prior authorization, adjudicate coverage, and manage utilization. It has been the highest-friction corner of healthcare AI: legislators, regulators, and clinicians have all taken direct aim at it, and 2026 has been a busy year on both sides.

Why this got contentious fast

Two things happened at once. The first is that health plans quietly deployed ML-driven prior-authorization systems at scale — some of them making initial denial decisions on hundreds of thousands of requests without human review at the first pass. Investigative reporting through 2023–2025 (STAT, ProPublica, HHS-OIG audits) surfaced enough class-action-worthy pattern-of-denial cases that Congressional oversight followed. The second is that generative AI made it dramatically easier for hospital revenue-cycle teams to submit more prior-authorization requests, on average better-supported, at higher levels of service. The PwC health-plan cost-inflator analysis projected this as a material driver of medical-loss-ratio pressure into 2027.

The result is an AI arms race with a policy layer sitting on top of it.

The 2026 rule stack

• CMS’s Interoperability and Prior Authorization Final Rule. Effective through 2026–2027, this rule forces Medicare Advantage, Medicaid managed-care, and other CMS-regulated plans to shorten decision windows, publish denial rates, and expose electronic prior-authorization APIs. Every plan has an ML system somewhere in that pipeline; the rule reshapes both the incentives and the audit surface.
• State-level PA reform. A growing patchwork of state laws (Texas, California, several others) restricting fully-automated denials and requiring physician review before adverse determinations.
• Federal action on algorithmic bias in coverage decisions. ACA §1557 non-discrimination requirements now explicitly reach automated decision tools used in coverage determinations.

Where the money is going

On the vendor side, capital is flowing into three buckets:

1. “Prior-auth automation for providers” — companies that use AI to prepare and submit PA requests on behalf of hospitals and clinics, minimizing physician time.
2. “Prior-auth intelligence for payers” — the counter-play: better ML for adjudication, coverage-policy management, and denial-rationale drafting.
3. “Revenue-cycle automation” — the broader wrapper around all of it: coding, charge capture, denials management, appeals drafting.

The interesting question — and the one we return to often in our reporting — is what the equilibrium looks like when both sides are augmented. Does it net out to more accurate care, or just an escalation of overhead?

What we cover

Our reporting in this topic focuses on: CMS rulemaking on prior authorization, state-level regulation of automated coverage decisions, litigation and settlements involving algorithmic denials, vendor category maps on both sides of the transaction, and the practical mechanics of how prior-authorization AI is deployed inside health plans and hospital revenue-cycle teams. Explore related articles and news below.